Infective endocarditis

Background

• Infection of heart valves, either prosthetic or native

Organisms

• Bacteria
  • Staphylococcus aureus (most common)
  • Viridans group streptococci
  • Coagulase-negative staphylococci
  • Other streptococci
  • Enterococci
  • HACEK group
  • Coxiella
  • Brucella
• Fungi
  • Candida

Clinical Presentation

• Refer to Modified Duke criteria
• Specific organisms may be associated with specific risk factors
  • Injection drug use: Viridans group streptococci and Pseudomonas aeruginosa
  • Colon cancer: [Streptococcus bovis]] and Clostridium septicum

Management

• Varies by causative organism and prosthetic vs. native valve

Indication	Antibiotic	Dose	Duration	Notes
MSSA and other oxacillin-susceptible Staphylococcus
NVE	oxacillin	12 g/day IV in 4-6 doses	6 weeks	can treat for 2 weeks in uncomplicated right-sided NVE
NVE	cefazolin	6 g/day IV in 3 doses	6 weeks	in patients with non-anaphylactoid penicillin allergy
PVE	oxacillin, plus	12 g/day in 6 doses	≥6 weeks	use cefazolin or vancomycin if allergy
	rifampin, plus	900 mg/day IV/PO in 3 doses
	gentamicin	3 mg/kg/day IV/IM in 2-3 doses	2 weeks
MRSA and other oxacillin-resistant Staphylococcus
NVE	vancomycin	30 mg/kg/day IV in 2 doses	6 weeks	target trough 10-20 μg/mL
NVE	daptomycin	≥8 mg/kg/dose	6 weeks
PVE	vancomycin, plus	30 mg/kg/day in 2 doses	≥6 weeks	target vancomycin trough of 10-20 μg/mL
	rifampin, plus	900 mg/day IV/PO in 3 doses
	gentamicin	3 mg/kg/day IV/IM in 2-3 doses	2 weeks
Enterococcus susceptible to penicillin and gentamicin
NVE or PVE	ampicillin, plus	2 g IV q4h	4-6 weeks	4 weeks if symptoms <3 months; 6 weeks if symptoms >3 months or if PVE
	gentamicin	3 mg/kg IBW in 2-3 doses
NVE or PVE	ampicillin, plus	2 g IV q4h	6 weeks	alternative regimen if CrCl <50
	ceftriaxone	2 g IV q12h
Enterococcus susceptible to penicillin and resistant to aminoglycosides
NVE or PVE	ampicillin, plus	2 g IV q4h	6 weeks
	ceftriaxone	2 g IV q12h
Enterococcus resistant to penicillin and susceptible to vancomycin and aminoglycosides
NVE or PVE	vancomycin, plus	30 mg/kg/day IV in 2 doses	6 weeks
	gentamicin	3 mg/kg/day IV/IM in 3 doses
Enterococcus resistant to penicillin, aminoglycosides, and vancomycin
NVE or PVE	linezolid	600 mg IV/PO q12h	>6 weeks
NVE or PVE	daptomycin	10-12 mg/kg/dose	>6 weeks
Viridans group Streptococcus or Streptococcus gallolyticus highly susceptible to penicillin
NVE	crystalline penicillin G	12-18 MU/day IV in 4-6 doses	4 weeks
NVE	ceftriaxone	2 g IV/IM q24h	4 weeks
NVE	penicillin or ceftriaxone, plus	as above	2 weeks
	gentamicin	3 mg/kg IV/IM q24h
NVE	vancomycin	30 mg/kg/day IV in 2 doses	4 weeks	use if allergy, target 10-15 μg/mL
PVE	crystalline penicillin G, or	24 MU/day IV in 4-6 doses	6 weeks
	ceftriaxone, with or without	2 g IV/IM q24h
	gentamicin	3 mg/kg IV/IM q24h	2 weeks
PVE	vancomycin	30 mg/kg/day IV in 2 doses	6 weeks	use if allergy
Viridans group Streptococcus or Streptococcus gallolyticus relatively resistant to penicillin
NVE	crystalline penicillin G, plus	24 MU/day IV in 4-6 doses	4 weeks
	gentamicin	3 mg/kg IV/IM q24h
NVE	vancomycin	30 mg/kg/day IV in 2 doses	4 weeks	use if allergy, target 10-15 μ/mL
PVE	crystalline penicillin G, or	24 MU/day IV in 4-6 doses	6 weeks
	ceftriaxone, plus	2 g IV/IM q24h
	gentamicin	3 mg/kg IV/IM q24h
PVE	vancomycin	30 mg/kg/day IV in 2 doses	6 weeks	use if allergy
HACEK bacterium
NVE	ceftriaxone	2 g IV/IM q24h	4 weeks
PVE	ceftriaxone	2 g IV/IM q24h	6 weeks
NVE or PVE	ciprofloxacin	1000 mg/day PO in 2 doses	6 weeks